Klinički bolnički centar Osijek središnja je i najveća zdravstvena ustanova u Slavoniji te jedan od pet kliničkih bolničkih centara u Hrvatskoj.

During the past decade, Clinical Hospital Centre Osijek conducted 64 clinical trials. In the 10-year time frame, 64 clinical trials started and 33 clinical trials were completed, i.e. on average, 51.6% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 28 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinical Hospital Centre Osijek" #1 sponsor was "Celgene" with 11 trials, followed by "Hoffmann-La Roche" with 10 trials sponsored, "Pfizer" with 6 trials sponsored, "Osijek University Hospital" with 5 trials sponsored and "Shire" with 5 trials sponsored. Other sponsors include 35 different institutions and companies that sponsored additional 33 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical Hospital Centre Osijek" #1 collaborator was "Gilead Sciences" with 2 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator and "Boehringer Ingelheim" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Clinical Hospital Centre Osijek" are "Ulcerative Colitis" (12 trials), "Crohn's Disease" (10 trials), "Crohn Disease" (9 trials), "Breast Cancer" (3 trials) and "Colitis, Ulcerative" (3 trials). Many other conditions were trialed in "Clinical Hospital Centre Osijek" in a lesser frequency.

Most popular intervention types in "Clinical Hospital Centre Osijek" are "Drug" (65 trials), "Other" (12 trials), "Biological" (4 trials), "Device" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (27 trials), "Ozanimod" (5 trials), "Etrolizumab" (4 trials), "Ontamalimab" (4 trials) and "Adalimumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Clinical Hospital Centre Osijek" are 73 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Clinical Hospital Centre Osijek". undefined are not yet recruiting, 16 are recruiting, 10 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 38 completed trials in Clinical Hospital Centre Osijek, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Clinical Hospital Centre Osijek, 1 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 58 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".